NDC 52536-134

Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate

Erythromycin Ethylsuccinate is a Oral Granule, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Wilshire Pharmaceuticals Inc.. The primary component is Erythromycin Ethylsuccinate.

Product ID52536-134_98a85646-cc9b-429f-9b46-4a3ce1b5c129
NDC52536-134
Product TypeHuman Prescription Drug
Proprietary NameErythromycin Ethylsuccinate
Generic NameErythromycin Ethylsuccinate
Dosage FormGranule, For Suspension
Route of AdministrationORAL
Marketing Start Date2016-09-28
Marketing CategoryNDA / NDA
Application NumberNDA050207
Labeler NameWilshire Pharmaceuticals Inc.
Substance NameERYTHROMYCIN ETHYLSUCCINATE
Active Ingredient Strength200 mg/5mL
Pharm ClassesDecreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 52536-134-13

100 mL in 1 BOTTLE (52536-134-13)
Marketing Start Date2016-09-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52536-134-13 [52536013413]

Erythromycin Ethylsuccinate GRANULE, FOR SUSPENSION
Marketing CategoryNDA
Application NumberNDA050207
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-09-28

Drug Details

Active Ingredients

IngredientStrength
ERYTHROMYCIN ETHYLSUCCINATE200 mg/5mL

OpenFDA Data

SPL SET ID:f4a3fffd-ce02-450f-bbcc-d425374e3e32
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 686400
  • UPC Code
  • 0300746302131
  • Pharmacological Class

    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]
    • Decreased Sebaceous Gland Activity [PE]
    • Macrolide [EPC]
    • Macrolide Antimicrobial [EPC]
    • Macrolides [CS]

    Medicade Reported Pricing

    52536013413 ERYTHROMYCIN 200 MG/5 ML GRAN

    Pricing Unit: ML | Drug Type:

    NDC Crossover Matching brand name "Erythromycin Ethylsuccinate" or generic name "Erythromycin Ethylsuccinate"

    NDCBrand NameGeneric Name
    0254-1020Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    0254-1021Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    24338-110ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-130ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-132ERYTHROMYCIN ETHYLSUCCINATEErythromycin Ethylsuccinate
    52536-134Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    52536-136Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-440Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-630Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    62559-631Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    63629-2500Erythromycin EthylsuccinateErythromycin Ethylsuccinate
    69238-1503Erythromycin EthylsuccinateErythromycin
    69238-1504Erythromycin EthylsuccinateErythromycin
    71209-102Erythromycin ethylsuccinateErythromycin ethylsuccinate
    71209-103Erythromycin ethylsuccinateErythromycin ethylsuccinate
    24338-100E.E.SErythromycin Ethylsuccinate
    24338-134E.E.SErythromycin Ethylsuccinate
    24338-136E.E.SErythromycin Ethylsuccinate
    24338-130Ery-PedErythromycin Ethylsuccinate
    24338-132Ery-PedErythromycin Ethylsuccinate

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.